Ivir News Today

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $9.18, but opened at $10.13. Vir Biotechnology shares last traded at $10.21, with a volume of 527,255 shares. The company reported ($0.48) earnings per share for the […]

Vir Biotechnology (NASDAQ:VIR – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Thursday, May 2nd. Analysts expect Vir Biotechnology to post earnings of ($0.99) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Vir […]

This is what i think, and hes proven wrong within seconds on a replay, why wasnt the decision changed . And thats where vir is so wrong, because it was there for all to see. , wrong, because it was there for all to see. ,. , to see. The Premier League has now resonded to see. The Premier League has now resuonded to to see. The Premier League has now responded to the to see. The Premier League has now responded to the statement. To see. The Premier League has now responded to the statement. They....

Affected the shootout that followed affected the shootout that followed. ,. , followed. The mentality changes because youve followed. The mentality changes because youve almost followed. The mentality changes because youve almost won followed. The mentality changes because youve almost won it,. Followed. The mentality changes i because youve almost won it, then youre told you havent won it, it just put you on the back for a little bit going into the penalty shoot out, you saw the reaction when i...

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) EVP Ann M. Hanly sold 2,711 shares of Vir Biotechnology stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $10.05, for a total value of $27,245.55. Following the sale, the executive vice president now directly owns 132,069 […]

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) CEO Backer Marianne De sold 72,995 shares of Vir Biotechnology stock in a transaction on Wednesday, April 3rd. The stock was sold at an average price of $9.46, for a total transaction of $690,532.70. Following the sale, the chief executive officer now owns 678,457 shares of the […]

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) CEO Backer Marianne De sold 72,995 shares of the business’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $9.46, for a total value of $690,532.70. Following the sale, the chief executive officer now directly owns 678,457 […]

Profund Advisors LLC grew its stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 51.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 91,038 shares of the company’s stock after acquiring an additional 31,029 shares during the quarter. Profund […]

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s share price was down 2.7% on Tuesday after an insider sold shares in the company. The stock traded as low as $11.42 and last traded at $11.58. Approximately 140,465 shares changed hands during trading, a decline of 87% from the average daily volume of 1,121,850 shares. The […]

Namita Thapar's sons Jai and Vir visit her on Shark Tank India 3 with their friends, making her the happiest mom. Namita is a powerful individual who appears on the business reality show as a Shark and is known for her great business concepts and investments in startups.